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ABSTRACT 
Background: Smoking cessation increases several symptoms, some of which appear to 
be due to nicotine withdrawal. One possible feature of withdrawal is impulsivity. 
Impulsivity is not currently included as a symptom of nicotine withdrawal neither in the 
Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) nor in 
withdrawal scales.  However, a related term, “impatience” is listed in some nicotine 
withdrawal scales. (Hughes J. R., Measurements of the Effects of Abstinence from 
Tobacco: A Qualitative Review, 2007).  Although impatience is not a synonym of 
impulsivity, both share the synonym “impetuous”. Therefore, impatience can be 
considered a measure of impulsivity. Although some reviews of the effect of smoking 
cessation on impatience have occurred, we know of no quantitative review of prospective 
studies of whether smoking cessation increases impatience. 
Purpose: To evaluate the effect of smoking cessation on impatience as measured by the 
Minnesota Nicotine Withdrawal Scale-Revised (MNWS). 
Methods:  A literature search of MEDLINE (PubMED), EMBASE, and PsychInfo was 
conducted.  Articles containing relevant keywords were reviewed by two evaluators 
independently.  To be considered for inclusion in the meta-analysis, studies had to be 
prospective studies, had to have pre-cessation impatience measurements, to include at 
least overnight abstinence, had to have smoking abstinence biochemically verified, and 
had to include effect size as an outcome measure.   
Results:  All pooled analyses were based on random-effects models. Seven trials met the 
selection criteria. The total number of subjects was 426.  There was a significant level of 
heterogeneity among studies (χ2 = 55.71 (6), p<0.0001) and  (I2 = 89%). The summary 
mean effect for impatience after tobacco cessation was an increase of .44 on a 0-3 scale 
(95% confidence interval [CI], 0.21-0.67) and a p-value<0.0001. 
Conclusion:  The meta-analysis shows that impulsivity increases post smoking cessation.  
These findings imply that smoking cessation may have an effect on decision making.  
Additionally higher rates of impulsivity have been associated with smoking relapse.  
(Doran, Spring, McChargue, Peradia, & Richmond, 2004).  In order to better assist in the 
development of individual treatments, a better understanding is needed of how increased 
impulsivity influences cognitive behavior and relapse rates.  These findings support the 
inclusion of impulsivity as a criterion for nicotine withdrawal.    
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GENERALIZED META-ANALYSIS AND STATISTICAL ANALYSIS MODELING  
 
Why Perform a Meta-Analysis:  
Advantages 
Synthesizing studies increases the power to detect a real effect as statistically significant 
if it exists.  Primary studies may be small and by combining them in a meta-analysis the 
precision of the estimated effect is improved.  Smaller studies have lower statistical 
power to reject the null hypothesis when it is false.  For example, several small studies 
may not have significant p-values giving the impression they had small effects, in fact 
they may have larger effects than larger studies that have reached significance. The 
synthesizing of apparently conflicting studies allows for the evaluation of the statistical 
significance of the estimated effect.  A meta-analysis is not only interested in the 
statistically significance of the effect but the magnitude and the direction of that effect 
The p-value only indicates that the  estimated effect is not zero but tells us nothing about 
the magnitude of the effect, which is what is meaningful to researchers and clinicians.  
Additionally, a primary study is targeted to a very specific population resulting in an 
estimated effect that is limited to that population, whereas, a meta-analysis allows for the 
combination of heterogeneous populations to determine a consistency of effects which is 
more generalizable. (Borenstien, Hedges, Higgins, & Rothstein, 2009) 
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Disadvantages 
Meta-analysis has limitations. There have been large randomized treatment studies 
performed studying the same question as a meta-analysis with a drastically different 
outcome. (LeLorier, Greoire, Benhaddad, Lapierre, & Derderian, 1997) A meta-analysis 
is only as good as its individual studies. If one of the large studies used in the meta-
analysis was poorly constructed it may have an adverse effect on the estimated effect.  A 
meta-analysis has several areas of potential bias, including inclusion/exclusion criteria 
used to select the studies and publication bias.  Another area of possible bias, or at least 
another limitation of meta-analysis, is combining findings across studies that are so 
heterogeneous that they perhaps should not be combined.  In these cases it can be 
misleading to present one average effect when maybe there are multiple true effects, none 
of which might be similar to the combined effect obtained from the meta-analysis. 
(Borenstien, Hedges, Higgins, & Rothstein, 2009) 
 
Generalized Statistical Approach 
 
The generalized statistical analysis follows the approach of Borenstein, Hedges, Higgins, 
and Rothstein, which begins with the calculation of the effect size for each study.  Next, 
the combination of the individual estimates is used to generate a summary effect. Fixed-
effects and random-effects models are used to fit the data. A compare and contrast 
between these models will be discussed in the following paragraphs. 
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Fixed-Effect Model 
 
The purpose of a fixed effect model is to estimate the unknown common effect size, µ 
and measure the accuracy of that estimation.  To estimate the common effect size, 
compute the summary effect which is the weighted mean of each study.  Compute the 
weighted mean by multiplying each study’s observed effect by its inverse variance. 
 
Consider a model comparing effect sizes  
 
𝑌𝑖 = 𝜇 + 𝜀𝑖       
 
Yi = observed effect size of the ith study.    
µ = is the common effect size i.e. the underling population effect size when there is no 
sampling error. 
εi = the within study sampling error for the ith study.     
 
The observation effect, Yi for each study is comprised of two components:  the unknown 
common “true” effect µ and the second component is the within study random sample 
error εi. 
Figure 1 illustrates that the observed effect Yi is assumed to be normally distributed about 
the unknown common effect size µ with the width of the curve based on the variance of 
the sampling error, σi 2. 
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  The common effect size µ is constant for all studies, which means the sampled 
population for each study is identical and any differences between studies is attributed to 
random sampling error, εi.  
 
 
 True Effect (µ) Observed Effect (Yi) 
Study   
Combined   
 
 
Figure 1 Fixed-Effect Model – True Effects and the Distribution of Sampling Error 
 
  
σ1 2 
σ2 2 
σ3 2  
ε1 
ε2 
ε3 
 
µ 
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Assumptions about the Fixed-Effects Model 
 
Yi ∼ Ν (µ, σi2),    ki ,..,1=  
 
Generally, the use of a fixed-effect model in a meta-analysis is inappropriate.  
Homogeneity among studies is essential for proper use of the fixed effects model.  
Although the studies in a meta-analysis are chosen because of their similarity to assume 
that each study is sampled from identical populations, i.e. same gender, same age, same 
race just to name a few characteristics is unrealistic.   
 
 
Effect Size Significance Testing 
 
In the fixed-effect model the null hypothesis is that there is zero effect in every study. 
  
𝐻0: 𝜇 = 0 
 
Limitations of the Fixed-Effect Model 
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The inferences from a fixed-effects model are restricted to the studies in the model and 
do not test whether effect size varies from study to study.  Researchers cannot illuminate 
if the intervention is impacted by the study sample. 
 
 
Performing a Fixed-Effect Meta-Analysis 
 
The goal of a fixed-effects meta-analysis is to estimate the common population effect, µ. 
Using the observed effects i.e. the collection of (Yi), we estimate the common effect. To 
get the most precise estimate, i.e. to minimize the variance, a weighted mean is 
computed.  Study weights are assigned to minimize the within study variance.  A weight 
is assigned to each study, with more weight given to larger studies.  The weight for a 
fixed-effect meta-analysis is  
𝑊𝑖 = 1𝑉𝑌𝑖 
 
where VYi is the estimate of within-study variance, σi2 .  The weighted mean (M), which is 
referred to as the “summary effect”, is then computed as 
 
∑
∑
=
== k
i
i
k
i
ii
W
YW
M
1
1 , 
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the sum of the products WiYi  (the observed effect multiplied by the weight) divided by 
the sum of the weights. 
 
The variance of the summary effect is estimated as the reciprocal of the weights and the 
estimated standard error of the summary effect is the square root of the variance. 
 
∑
=
= k
i
i
M
W
V
1
1
  
 
MM VSE =   
 
The 95% lower and upper limits for the summary effect are estimated as 
 
MM SEMLL ×−= 96.1  
MM SEMUL ×+= 96.1  
 
To test  0:0 =µH  namely, that the true effect µ is zero, a two sided Z test is performed. 
 
MSE
MZ =  
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Identifying Heterogeneity: Q Statistic 
 
The Q statistic, also known as the χ2  heterogeneity test, is a method of identifying the 
variation of true effect sizes µ from study to study.  Heterogeneity of effect sizes is the 
variation of the true effect sizes. 
 
In order to extract the between-study variation from the observed variation the following 
process is applied. 
 
1. Compute total observed study to study variation. 
2. Estimate how much the observed effects would be expected to vary between-
studies if there were a true common effect. 
3. The difference between the observed variation and the expected variation 
quantifies the real differences in effect size i.e. heterogeneity. 
 
The Q statistic is used to analyze and partition the total observed variation. 
 
Derivation of the Q statistic 
 
Q is a weighted sum of squares.  To compute Q, subtract each of the effect sizes (Yi) from 
the mean (summary effect size M), square it, weight this by the inverse-variance (Wi) for 
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the study, and then sum these values over all studies to get the weighted sum of squares 
(WSS). (Borenstien, Hedges, Higgins, & Rothstein, 2009) 
 
( )2
1
MYWQ i
k
i
i −= ∑
=
 
 
 
For easier computation 
∑
∑
∑
=
=
=






−= k
i
i
k
i
iik
i
ii
W
YW
YWQ
1
2
1
1
2  
Expected value of Q 
  
The expected value of Q is based on the assumption that each study shares a common 
effect size µ and any variation is due to sampling error within studies. The expected value 
of Q is equal to the degrees of freedom (df). (Borenstien, Hedges, Higgins, & Rothstein, 
2009) 
 
( ) 1−== kdfQExpected , 
 
where k is equal to the number of studies. When there is no heterogeneity in effect sizes, 
Q is distributed as χ2  with k-1 (df). 
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The excess variation is computed by the observed WSS (Q) minus the expected WSS 
(df).  This difference is the excess variation of the true effects attributed to the variation 
study to study, namely heterogeneity. 
 
dfQ −  
 
Quantifying Heterogeneity: T and I2 
 
Whereas the Q statistic identifies the existence of heterogeneity, T2  and T reflect the 
amount of heterogeneity.  T2  is an estimate of τ2 the between-studies variance and T is the 
standard deviation of the true effects.  In a meta-analysis it is important to report the 
summary effect and explain the dispersion of true effects (T) similar to a primary study 
where the mean and the standard deviation are reported. 
 
To estimate the variance and the standard deviation T2 and T use Q and remove the 
dependence on the number of studies returning it to the original metric. (Higgins & 
Green, 2011) 
To compute T2 and T 
1. Take the difference (Q – df ), which is standardized  dispersion  of the true effects 
2. Divide by quantity C which puts the measurement back into original units and 
making it an average, rather than a sum of squared deviations 
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C
dfQT −=  
where 
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=
=
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
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1−= kdf  
 
where k is the number of studies, and 
 
∑
∑
∑
=
=
=
−= k
i
i
k
i
ik
i
i
W
W
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1
1
2
1
 
T2 is in the same unit measurement (squared) as the effect size and represents the absolute 
amount of variation in that scale. (Borenstien, Hedges, Higgins, & Rothstein, 2009) 
 
I2 is a descriptive statistic that is the proportion of the real differences in effect size to the 
total variance.  The term “real differences” refers to differences in effect size that is not 
attributed to random error.  To compute I2 
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𝐼2 = 𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒𝐵𝑒𝑡𝑤𝑒𝑒𝑛
𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒𝑇𝑜𝑡𝑎𝑙
= �𝑄 − 𝑑𝑓
𝑄
� × 100% 
 
I2  values of  25%, 50%, and 75%   are considered low, moderate, and high proportions of 
heterogeneity, respectively. 
 
Random-Effects Model  
 
The purpose of a random-effects model is to estimate the mean distribution of the effect 
sizes, µ and measure the accuracy of that estimation.  Unlike a fixed-effects model, for a 
random-effects model there is no assumption that each study is estimating the same effect 
size µ.  To estimate the mean effect size compute the summary effect, this is the weighted 
mean of each study.  Compute the weighted mean by multiplying each study’s observed 
effect by its inverse variance. However, the variance in a random-effects model is 
calculated differently than a fixed-effects model and will be discussed in the following 
paragraphs. 
 
Once again, consider a model comparing effect sizes  
 
𝑌𝑖 = 𝜇 + ς𝑖 + 𝜀𝑖 
 
Yi = observed effect size of the ith study.    
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µ = is the mean of the population distribution of effect size.  
εi = the within study sampling error for the ith study.  
ςi = true effect of studyi . 
 
Figure 2 illustrates the distribution of three studies drawn from the distribution of studies 
depicted by the normal curve. The observation effect, Yi for each study is comprised of 
two components.  The true effect µ plus the random true effect of studyi, ςi, the second 
component is the within study random sampling error εi.  
 
 True Effect (µ) Observed Effect (Yi) 
Study   
Combined   
 
 
Figure 2 Random-Effects Distribution 
 
     
 
 
σ12 
σ22 
σ32 
ς1 ε1 
ε2 
ς2 
ε3 
ς3 τ2 
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Assumptions about the Random-Effects Model 
 
εi ∼ Ν (0, σi2),    ki ,..,1=  
ςi ∼ Ν (0, τ2),    ki ,..,1=  
 
Random-effects meta-analysis sampling is a two stage process.  First, a random sample of 
studies is acquired from a larger population of studies whose true effects can be different 
for each study. The true effect is sampled from a distribution with mean µ and variance 
τ2. In the second stage, a random sample of subjects is selected from a larger population 
of subjects.  Yi is sampled from a distribution of the true effects and variance σi2.  
(Cooper, Hedges, & Valentine, 2009) 
 Variance (Yi ) = σi2+ τ2 
 
Effect Size Significance Testing 
 
In the random-effect model the null hypothesis is that there is zero average effect across 
studies.  
Ho: µ = 0 
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Limitations of the Random-Effects Model 
 
The studies in the model may be too heterogeneous to combine in a meta-analysis 
rendering any summary effect non-informative. 
 
Performing a Random-Effects Meta-Analysis 
 
The goal of the random-effects meta-analysis is to estimate the range of population 
effects. In the random-effects model the summary effect is used to estimate the mean 
distribution population effect. To get the most precise estimate, i.e. to minimize the 
variance a weighted mean is computed.  A weight is assigned to each study.  This is the 
reciprocal of the study’s total variance.   Unlike the fixed-effects model,  larger studies 
are not assigned more relative weight and smaller studies are not assigned less relative 
weight because each study in the analysis represents a unique population.  (*) denotes 
random-effects model.  The weight for a random-effects meta-analysis  
 
*
* 1
Yi
i V
W =  
 
Where V*Yi is the sum of the estimate of within-study variance (VYi) and the estimate of 
the between study variance (T2).  
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TVV YiYi
2* +=  
 
where,             𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 𝑜𝑓 𝜎2 = 𝑉𝑌𝑖 
                                    𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 𝑜𝑓 𝜏2 = 𝑇2 
 
 
The weighted mean (M), which is referred to as the “summary effect”, is then computed 
as 
∑
∑
=
== k
i
i
k
i
ii
W
YW
M
1
*
1
*
*  
the sum of the products WiYi (the observed effect multiplied by the weight) divided by the 
sum of the weights. 
 
The variance of the summary effect is estimated as the reciprocal of the weights and the 
estimated standard error of the summary effect is the square root of the variance. 
 
∑
=
= k
i
i
M
W
V
1
*
*
1
   
 
** MM VSE =    
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The 95% lower and upper limits for the summary effect are estimated as 
 
*
*
* 96.1 MM SEMLL ×−=  
*
*
* 96.1 MM SEMUL ×+=  
 
To test  0:0 =µH  namely that the true effect µ is zero a two sided Z test is performed. 
 
*
*
*
MSE
MZ =  
 
 
Forest Plot 
A Forest Plot is a graphical representation of the meta-analysis results. To illustrate, 
suppose a meta-analysis is performed using four studies A, B, C, and D.  In Figure 4, 
there are four squares with a horizontal line representing the four individual studies in the 
analysis.  The size of the square is proportional (in area) to that study’s weight in the 
analysis.  The diamond represents the summary effect from the analysis. The vertical line 
centered at zero represents a null effect. The horizontal lines represents the confidence 
interval for each study.  The length of the line illustrates the precision or imprecision of 
the point estimate.  If the horizontal line crosses the vertical line then that study has an 
insignificant result.  Studies C and D cross the vertical line and therefore contains the null 
18 
 
Impact of Intervention 
Summary Effect 
A 
B 
0         
     Effect Size 
C 
D 
result. The middle of the diamond is the summary effect and its width is the confidence 
interval. 
 
 
 
 
 
 
 
 
 
 
Figure 3 Example of a Forest Plot 
 
Publication Bias 
Publication bias can be a serious problem in health research and systematic reviews. Not 
all studies are published.  Published and unpublished studies frequently have different 
results. It is accepted knowledge that larger studies and studies with statistically 
significant results are more likely to be published than smaller studies and studies with 
statistically non-significant results (Cooper, Hedges, & Valentine, 2009).  Compounding 
this problem is that well designed and conducted research tends to produce more 
statistically non-significant results; hence less likely to be published.  If published 
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research is a biased sample of all conducted research then the validity of the resulting 
inferences will be questionable, usually overestimating the true effect size because the 
studies are unrepresentative of the research population. (Sciences) 
 
Identifying Publication Bias: The Funnel Plot 
A funnel plot is a graphical method of detecting publication bias.  It is a plot of estimates 
of effects versus measures of their precision for each of the primary studies in the meta-
analysis.  It is called the “funnel” plot because studies of smaller size (less precision) will 
have a wider distribution of results than studies of larger size, due to a higher variation.  
If publication bias is absent you should expect a symmetrical funnel about the true 
population effect size where less precise studies should be scattered to either side of the 
more precise studies. (Song, Khan, Dinnes, & Sutton, 2002) 
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Figure 4 Example of a Symmetrical Funnel Plot 
 
However; if a funnel plot is asymmetrical there may be other explanations other than 
publication bias. If a meta-analysis consists of a small number of studies or high 
heterogeneity between studies an inaccurate or asymmetrical funnel plot may be 
generated.   
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Assessing the Impact of Publication Bias: Fail-Safe N 
 
The objective of the Fail-Safe N method is to determine the number of unpublished 
research (k0) with an average null effect of zero that would bring the overall summary 
effect to statistical non-significance i.e. p > 0.05.  If it is determined that k0 is so large that 
it is implausible there is that much unpublished research in existence then we can be 
confident that the statistical significance of the observed effects is likely to be true. To 
determine if k0 is realistically achievable it should not exceed a calculated tolerance level. 
(Cooper, Hedges, & Valentine, 2009) To compute k0 and the appropriate tolerance level 
𝑍 = ∑ 𝑍𝑖𝑘1
√𝑘
 
where k is the number of studies  
∑ 𝑍𝑖
𝑘
1
�𝑘 + 𝑘0 < 𝑍∝ 2⁄  
 
that is 
𝑘0 > −𝑘 + �∑ 𝑍𝑖𝑘1 �2
�𝑍∝ 2⁄ �
2  
 
 
with a tolerance level   
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5𝑘 + 10 
 
So k0 ≥ 5k + 10, implies that if “5k + 10” or more studies are un-retrieved with zero 
effect, (compared to the published studies used in the research), on average, the meta-
analysis would not reach statistical significance at the five percent level of significance. 
(Borenstien, Hedges, Higgins, & Rothstein, 2009) 
There are several drawbacks to the Fail Safe N method: it does not consider sample size; 
it assumes a zero null effect for the unpublished studies, where the average effect may 
really be a non-zero effect; and the heterogeneity among studies is not considered, to 
name a few.  Therefore, this method should be viewed as a useful, simple but rough 
method of assessing the impact of publication bias. 
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THE META-ANALYSIS OF STUDIES INVESTIGATING THE EFFECT OF 
SMOKING CESSATION ON IMPATIENCE 
 
Background and Literature Review 
 
Smoking cessation increases several symptoms, some of which appear to be due to 
nicotine withdrawal. (Shiffman, West, & Gilbert, August 2004)  One possible feature of 
withdrawal is impulsivity. 
Impulsivity is a broad concept that has been defined and measured differently by authors.  
The most widely included measures are self-reports of the adjective “impulsivity” or high 
scores on multi-item scales of impulsivity (Ashare & Hawk Jr., 2012) such as: 
Delay discounting which is a measure of the degree to which an individual is driven by 
immediate gratiﬁcation vs. the prospect of larger, but delayed rewards in either 
hypothetical or real delay scenarios. (Reynolds, Ortengren, Richards, & de Wit, 2006) 
Response inhibition, often defined as an inability to inhibit false positive responses on a 
vigilance task i.e. the inability to suppress actions that are inappropriate in a given 
context and that interfere with goal-driven behavior. (Logan, Schachar, & Tannock, 
1997). 
Pre-pulse inhibition is the ability of a weak warning stimulus to reduce the impulsive 
reaction to a strong stimulus.  (Ashare, Hawk, & Mazzullo, 2007) 
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Impulsivity is not currently included as a symptom of nicotine withdrawal neither in the 
Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) 
[American Psychiatric Association], International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM) nor in withdrawal scales.  However, a 
related term, “impatience” is listed in some nicotine withdrawal scales. (Hughes J. R., 
2007)  Although impatience is not a synonym of impulsivity, both share the synonym 
“impetuous”. Therefore, impatience can be considered a measure of impulsivity.  
Although some reviews of the effect of smoking abstinence on impatience, delay 
discounting, and response inhibition have occurred, we know of no quantitative review of 
prospective studies of whether smoking cessation increases one of the above measures of 
impulsivity.   A meta-analysis of literature findings would be useful to strengthen the 
evidence of an association between smoking cessation or smoking deprivation and 
increased impulsivity. 
 
Methods 
 
The PRISMA statement for reporting systematic reviews and meta-analyses of studies 
that evaluate healthcare interventions was used in the reporting of the research 
methodology and its results. (Liberati Alessandro, 2009) 
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Definition of Terms 
There are several terms in the literature that are used interchangeably to describe the 
discontinuation of tobacco: abstinence, cessation, deprivation, quitting, and stopping. For 
simplicity and clarity, this research will use the Hughes, 2007 recommended terms: 
abstinence, cessation, and quitting referring to smokers who are trying to stop smoking 
permanently and use of deprivation to refer to experimenter-instructed temporary 
discontinuation of tobacco use in smokers not trying to stop tobacco use permanently. 
In addition to withdrawal effects there is another post-cessation phenomenon called offset 
effect.  The distinction between withdrawal effects and offset effects is that withdrawal 
effects are a time limited pattern of symptoms that may increase or decrease.  “Whereas, 
offset effects are abstinence effects with a unidirectional change from the typical values 
of a smoker i.e. the simple termination of the chronic effects of tobacco.” (Hughes J. R., 
p. 128). For example, once a smoker comes out of withdrawal the continuation of a 
symptom may be the return to the original state of that individual prior to smoking; and it 
is that original state of being that may have led to the need to begin smoking i.e. an 
anxious individual may have begun smoking to reduce their anxiety.  Therefore, smoking 
has a calming effect and reduces anxiety, the discontinuation of smoking may increase 
anxiety and “level off “at pre-smoking levels. That “level off” is the offset effect. 
Lastly, impatience is the only measure of impulsivity that is included in this meta-
analysis.   This is because, as described below, there were an insufficient number of 
studies that measured ratings of “impulsiveness,” delay discounting, response inhibition 
or pre-pulse inhibition.  
26 
 
 
Initial Eligibility Criteria  
Prospective studies of smoking cessation or smoking deprivation that measured self-
reported impatience, at least once during smoking and once during abstinence within the 
same participants. The cessation could be experimenter or subject-induced.  Smokers 
could or could not be trying to stop for good.  Analyses could be based on all participants 
or only those who successfully abstained.  Studies in any language and any year were 
eligible.  Unpublished studies were eligible.  Participants had to be current daily smokers 
greater than 18 years old. Participants could not have received a treatment. Abstinence 
duration must be more than overnight abstinence and abstinence verification less than 
two weeks after smoking cessation begins. 
 
Information Sources  
A reference librarian independently searched CINAHL, Medline, and PsychInfo.  
Authors used supplementary approaches to identify such as hand searching journals, and 
checking reference lists.  Search terms included “cigarettes, nicotine, smoking, or 
tobacco” AND “abstain, abstinence, cease, cessation, quit, or stop,” AND “impulsivity, 
response inhibition, delay discounting, restless”, and their stems in the title or abstract or 
keywords and MESH terms.   All years were included.  We added to this, articles already 
obtained by authors, and relevant citations in the texts obtained.  The total number of 
articles examined was 726 (which include overlap across multiple databases). 
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Sample Search Strategy 
Table 1 Medline Search
 
 
Study Selection  
The author and rater (MD and JH) independently examined titles to decide which papers 
to proceed to reading of their abstracts.  This eliminated 639 articles.  Kappa for Inter-
rater agreement reviewing titles was 0.83. The raters then independently read abstracts 
searching for key study criteria,: abstinence greater than 12 hours, prospective study, 
baseline and post abstinence impulsivity measurement, verification of abstinence, and 
adult participants who smoked at least  ten cigarettes per day to independently decide 
which papers to proceed to reading the entire articles Disagreements were resolved by 
mutual consent.  This eliminated another 59 articles Kappa for inter-rater agreement on 
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complete papers to review include was 0.80.  .Finally, the raters independently read entire 
articles and decided which papers would be included in the meta-analysis (Figure 1).  
This eliminated another 19 articles.   Kappa for inter-rater agreement for papers to 
include in the meta-analysis was 1.00. 
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Figure 5 Flow of information through the different phases of the systematic review 
  
After reviewing selected articles (n=9), the authors decided to expand the search criteria 
because there were not enough studies in any particular category of impulsivity for a 
meta-analysis. The authors reviewed and now included (if appropriate) the following type 
Literature Search 
Databases: Medline,CINAHL, 
PscyhInfo and John Hughes 
Articles screened on basis of title  
Excluded (n=639) 
Included (n=87) 
Articles screened on basis of abstract 
 Reasons for Exclusions: no impulsivity (n=26)  
not prospective study(n=16) Overnight Abstinence(n=17) 
Excluded (n=59) Included (n=28) 
Articles review and application of inclusion criteria Excluded (n=19, no impulsivity measure) 
Included (n=9) 
Added 6 new articles  
Final selection for review (n=15)  
Measured impatience (n=6, and included) 
Other measures of impulsivity (n=9, and excluded) 
Final included articles for meta-analysis (n=6) 
Search Results combined (includes overlap 
across multiple databases n=726) 
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of articles: abstracts that had been excluded for ‘overnight abstinence’, abstracts that 
were excluded because they lacked impulsivity measurement but had an “impatience” 
measurement.  In addition, the raters located an additional 6 articles from the reference 
section of reviewed articles.   
With these changes, there were still too few studies of self-rated impulsivity, response 
inhibition, delay discounting or pre-pulse inhibition that used sufficiently similar 
measures to undertake a meta-analysis.  However, there were six studies that met the 
criteria and used similar measures of impatience. One study included two groups 
(pregnant and non-pregnant smokers) which were analyzed separately, so there were a 
total of seven pre/post comparisons available for the meta-analysis. 
 
Data Collection Process 
A data extraction sheet to code information for the six included studies was created.  One 
review author extracted the following data from the included studies and the second 
author checked the extracted data.  Disagreements were resolved by discussion between 
the two review authors.   
Data Items 
Information was extracted from each study on: characteristics of study participants 
(including mean age, gender, race, mean Fagerstrom Test for Nicotine Dependence                        
(FTND) score) trial’s inclusion and exclusion criteria; duration of smoking cessation, 
frequency of  the Minnesota Nicotine Withdrawal Scale-Revised (MNWS) 
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measurements, whether a special population was used,  pre/post impatience score, their 
change score and its standard error of the mean, and length of follow up.  
For four of the seven comparisons, standard deviations for the pre and post impatience 
scores were presented but not the standard deviation for the within-subject differences in 
impatience.  As a result, the standard deviation for the within subject differences was 
estimated from the between subject standard deviation and the estimated within subject 
correlation (r). (Cooper, Hedges, & Valentine, 2009, pp. 229-230)  The meta-analysis 
was performed both using r = 0.6 for the studies that did not report the standard deviation 
for the change in impatience.  
 
Risk of Bias within Individual Studies 
In a meta-analysis to be confident that the reported intervention effects are accurate 
depends on the validity of the included studies.  To ascertain the validity of eligible 
randomized studies the author determined the adequacy of randomization, and 
concealment of allocation, blinding of participants and data collectors; and the extent loss 
to follow-up using the Cochrane Collaboration’s tool for assessing risk of bias in 
randomized trials. (Higgins, Altman, Gotzche, & Juni, 2011) 
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Table 2 Cochrane Collaboration’s Summary Assessments 
Risk of bias Interpretation Within a study Across studies 
Low risk of bias 
Plausible bias 
unlikely to seriously 
alter the results. 
Low risk of bias for all key 
domains. 
Most information is 
from studies at low risk 
of bias. 
Unclear risk of bias 
Plausible bias that 
raises some doubt 
about the results 
Unclear risk of bias for one or 
more key domains. 
Most information is 
from studies at low or 
unclear risk of bias 
High risk of bias 
Plausible bias that 
seriously weakens 
confidence in the 
results. 
High risk of bias for one or more 
key domains. 
The proportion of 
information from 
studies at high risk of 
bias is sufficient to 
affect the interpretation 
of the results 
 
 
  
Figure 6 Author’s judgments about each risk of bias item presented as percentages across all included studies. 
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Table 3 Risk of Bias Summary: Author’s judgments about each risk of bias item for each included study. 
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Characteristics of Included Studies 
 
 Table 4 Comparisons’ Characteristics  
Study Sample (N) Mean Age %Female %Minority Cigarettes per day
What treatments were used to induce 
abstinence 0 = None; 
2 = Money; 3 = Other
Etter 65 37 66% _ 15 0
Heil 27 25 100% 4% 7 3
Hughes, 1986 50 38 54% _ _ 3
Hughes, 1991 105 36 59% _ 29 3
Jorenby 106 42 52% 3% 29 3
Ussher, Preg 20 29 100% 94% 14 0
Ussher, non-Preg 95 29 100% 94% 15 0
Special Population: 
0=No,1=High Impulsivity 
Score 2=Psychiatric 
Disorder, 3= Pregnant
Fagerstrom Test of 
Nicotine 
Ddependence
Abstinence 
Verified  
1=Yes, 0=No
No. hours 
after 
abstinence 
was the first 
measure of 
impatience
Was Placebo used 
during abstinence 
period?
1 = yes; 0 = no
Percent of subjects dropped out before last 
measure within 2 week period
Etter 0 4.6 0 168 0 76%
Heil 3 _ 1 120 0 44%
Hughes, 1986 0 _ 1 144 1 0%
Hughes, 1991 0 5.8 1 168 1 22%
Jorenby 0 6.8 1 168 1 39%
Ussher, Preg 3 5.2 0 24 0 49%
Ussher, non-Preg 0 4.6 0 24 0 49%
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Table 5Study Description and Design 
Study Description 
Etter, Jean, et al. 2012 In an internet-based study, daily smokers were assigned randomly to continue to smoke 
for 2 weeks (n=539) or to stop smoking (n=297). Only the latter group was included in the 
meta-analysis).  Participants answered followed up surveys 1, 3, and 7 days after their 
target quit date.  The study measured tobacco withdrawal symptoms using Minnesota 
Nicotine Withdrawal Scale.  Impatience significantly decreased.  The authors did not 
expect that abstinence would have significantly decreased impatience. (Etter, Ussher, & 
Hughes, 2012) 
Heil, Sarah, et al. 2006 The aim of this study was to characterize nicotine withdrawal and craving in pregnant 
cigarette smokers. Participants self-selected into the abstainer or smoker categories.  The 
authors examined results from the Minnesota Nicotine Withdrawal Scale in abstainers 
(n=27 this group was included in the meta-analysis) and smokers (n=21). Participants 
attended daily abstinence monitoring sessions during the first five days of the quit 
attempt.  Impatience significantly increased more in abstainers than smokers. The results 
suggest that pregnant smokers generally may have elevated baseline levels of 
withdrawal. (Heil, Higgins, Mongeon, Badger, & Bernstein, 2006) 
Hughes, John, et al. 1986 Smokers were randomly assigned to receive placebo gum (n=50 this group was included 
in the meta-analysis) or nicotine gum during a double blind study of the effect of nicotine 
gum on the self-reported using the Minnesota Nicotine Withdrawal Scale. Smokers were 
counseled about smoking cessation for less than ten minutes.  Impatience significantly 
increased after smoking cessation in the placebo group. (Hughes & Hatsukami, Signs and 
Symptoms of Tobacco Withdrawal, 1986) 
Hughes, John, et al. 1991 Smokers were randomly assigned to receive placebo gum (n= 105 this group was included 
in the meta-analysis) or nicotine gum (n=210) during a double blind study of the effect of 
nicotine gum on the self-reported using the Minnesota Nicotine Withdrawal. The self-
reports were collected 1-2 weeks, 1 month, and 6 months. Impatience significantly 
increased post tobacco cessation. (Hughes, Gust, Skoog, Keenan, & Fenwick, 1991) 
Jorenby, Douglas, et. al. 
1996 
This was a 5 week multi-site, double-blind nicotine vs placebo gum controlled trial. 
Participants were randomly assigned to either active (n=105) or placebo treatment gum 
(n= 106 this group was included in the meta-analysis).  Adjuvant treatment consisted of 
group counseling lasting 1 hour.  In addition to the pre-quit visit, groups met three times 
in each of the two weeks following the quit date, and twice in both the third and fourth 
week post quit for a total of 11 sessions.  The study examined smoker’s self-reported 
withdrawal symptoms using the Minnesota Nicotine Withdrawal Scale.  Impatience 
significantly increased in the placebo and active group after smoking cessation. (Jorenby, 
et al., 1996) 
Ussher, Michael, et al. 
2012 
For the meta-analysis the pregnant abstainers (n=20) and the non-pregnant abstainers 
(n=95) were analyzed as two separate analyses, Ussher, 2012a and Ussher, 2012b, 
respectively. This study compared tobacco withdrawal using the Minnesota Nicotine 
Withdrawal Scale in pregnant and non-pregnant smokers that abstained for 24 hours.  
Participants were randomized to either abstain from smoking for 24 hours or smoke as 
usual.  Impatience significantly increased with smoking cessation. (Ussher, Etter, Giatras, 
& Coleman, 2012) 
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Statistical Analysis and Results  
Effect Size Based On Mean in a Pre-Post Design 
This analysis used the raw unstandardized mean difference because the reported outcome 
for all the included studies used the Minnesota Nicotine Withdrawal Scale-Revised 
(MNWS) and performing the analysis directly on the raw mean difference was intuitively 
meaningful and the use of the MNWS scale is widespread.   This analysis used the 0-3 
MNWS scale.  Those studies that provided a 0-4 MNWS were converted to the 0-3 
MNWS scale along with their associated standard deviations.  This analysis used the 
average of the post cessation MNWS repeated measurements as a single score. 
 
Effect size was the mean difference between pre and post cessation impatience scores.  
The true population means of the pre-post design is µ1 and µ2  and the population mean 
difference is defined as  
𝜇 = (𝜇2 − 𝜇1) 
 
The unbiased estimator of µ is Yi the sample mean difference.  
 
For fixed-effect meta-analysis, the effect sizes for each study are fixed and are unknown 
constants.  In a random-effects meta-analysis, the true effect size for each study is 
different and normally distributed and independent. 
 
Yi~ N (µ+ςi, σi2), i = 1,…, k 
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The goal of this analysis was to determine if there is a significant change in the 
impatience score post smoking cessation, as well as provide a confidence interval for that 
change score.  The mean difference with 95% CIs were calculated for the pooled 
estimates. A mean difference > 0 indicates that impatience increased and a mean 
difference < 0 indicates that impatience decreased.  Heterogeneity was assessed by 
examining the forest plots of the seven comparisons, by performing the χ2 heterogeneity 
test, and I2 statistics. Data management and analysis were carried out in Review Manager 
5.2. and verified using excel 2010. 
Prior to any statistical analysis the random-effects model was chosen because the subject 
populations varied study to study and the timing and number of post cessation impatience 
measurements vastly differed among studies (see Table 6).  For the sake of analytical 
comparison we also performed analysis using the fixed-effects model. 
 
Fixed-Effect Meta-Analysis 
The summary common effect for impatience after tobacco cessation was an increase of 
0.51 on a 0-3 scale (95% CI [0.44, 0.59]).  There was a significant level of heterogeneity 
(χ2 = 55.71 (6), p<0.0001) indicating using the random-effects model for this meta-
analysis was more appropriate (see Table 6). 
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Table 6 Fixed-Effects Meta-Analysis Results and Forest Plot 
 
 
The summary effect for impatience after tobacco cessation in the random effects model  
was an average increase of 0.44 on a 0-3 scale, p < 0.00001 [95% CI [0.22, 0.67].  
(Table 7) 
 
Table 7 Random-Effects Meta-Analysis Results and Forest Plot 
 
 
Six of the seven comparisons showed a significant increase in impatience with smoking 
cessation.  The remaining comparison Etter, 2012 showed a non-significant decrease in 
impatience.  There was considerable heterogeneity between studies I2 = 89%.  This 
heterogeneity was substantially attributed to the Etter, 2012 study.  This was the only 
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study that showed a decrease in impatience, albeit a statistically insignificant decrease,  
([-0.12, 95% CI [-0.32, 0.08]).  As a sensitivity analysis, the Etter, 2012 study was 
removed from the data and heterogeneity was reassessed on the remaining data with the 
following results:  (0.58, 95%CI [0.46, 0.69]); T² = 0.01; χ² = 9.38 (5), (p = 0.09);             
I² = 47% and Z = 10.02 (p < 0.00001).  Removing the Etter, 2012 study increased the 
effect size estimate and reduced heterogeneity to a statistically insignificant level while 
maintaining a significant summary effect confirming it as a major source of variation.  
The confidence interval tells us how confident we can be in the effect size.  Ideally, the 
narrower the interval the more confident we should be in the effect size estimate.  The 
confidence interval for the random-effects analysis [0.22, 0.67] was wider than the fixed-
effects analysis [0.44, 0.59] because the summary effect is a less precise estimate because 
of the increase variation due to heterogeneity.  This same information is presented 
graphically in Table 7 and Table 8.  Each study is represented by a box and bounded by a 
confidence interval and the combined results and confidence interval is shown by the 
diamond.   
Assessing publication bias was addressed using the funnel plot and the fail-safe N 
methods. Figure 7 is asymmetric funnel plot and gives the appearance of potential 
publication bias; however, with only seven comparisons in this meta-analysis and I2 of 
89% an asymmetrical funnel plot is not unexpected regardless of the possibility of 
publication bias. 
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FUNNEL PLOT OF RANDOM EFFECTS ANALYSIS 
 
Figure 7 Funnel plot of effect size estimates for all individual comparisons in the meta-analysis 
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Next, to assess the potential for publication bias to have influenced the results of this 
meta-analysis we calculated the ‘fail-safe N’, the number of additional ‘negative’ studies 
(studies in which the intervention average effect is zero) that would be needed to increase 
the P value for the meta-analysis to above 0.05.  To that end, individual z scores were 
computed by dividing the effect size by the corresponding standard errors. This lead to 
∑zi = 12.49; k0 > -7 + (33.03/1.96)2 leading to k0 ≥ 277.  If there were 277 unpublished 
studies with the mean null effect of zero than the results of the meta-analysis would be 
reversed; However 277 unpublished studies far exceeds the tolerance level of                 
5k + 10 = 45 and it can be inferred that it is unrealistic to believe there are 277 un-
retrievable studies therefore; the result of the observed effects were not affected by 
publication bias. 
Discussion 
The meta-analysis revealed that nicotine withdrawal significantly increases impulsivity as 
measured by a significant increase of impatience over baseline ratings. 
This meta-analysis has several strengths and some limitations that deserve mention.  The 
strengths include the comprehensive search strategy that improved the likelihood of 
identifying all relevant studies.   Over 700 citations were searched and 28 articles were 
read.  An independent parallel process for selecting studies and the extraction of data 
reduced the potential for bias.  The included studies used a well-established scale to 
measure impulsivity.  Six of the seven comparisons were randomized trials which would 
have reduced the likelihood of systematic error.   
42 
 
Fail Safe N method suggests the summary effect was not influenced by publication bias 
and did not contribute to the asymmetry of the funnel plot and is not the cause of any 
unexplained heterogeneity.  
Limitations 
The meta-analysis had a relatively small sample size which limited our options for 
statistical analysis.  There was statistical evidence of substantial heterogeneity.  The 
major source of the heterogeneity and funnel plot asymmetry was the inclusion of the 
Etter, 2012 study.  This study found a statistically insignificant decrease in impatience 
after smoking cessation compared with the pre-cessation impatience score.  Etter explains 
that the unexpected result was attributed to the fact that it was an internet study which 
may have caused a reactivity effect; i.e. repeated self-measures may modify symptoms 
and behaviors.  A meta-analysis excluding this study resulted in an increase in the 
estimate and the heterogeneity was reduced to statistical non-significance. It is this 
author’s belief that the Etter, 2012 study was an outlier and is inconsistent with other 
impulsivity research outcomes.   
The meta-analysis had some “unclear risk” of selection bias. The Cochrane Collaboration 
tool for assessing risk of bias of randomized trials sets a high bar.  Few published studies 
report or make available the necessary information to objectively assess the risk of bias 
for all categories of interest.  This was especially true for this meta-analysis, few studies 
discussed allocation concealment which refers to “techniques used to implement the 
allocation sequence, not to generate it” (Higgins, Altman, Gotzche, & Juni, 2011). 
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In general, high risk of bias was not an issue for this meta-analysis, even though  Heil 
2006 was not a randomized trial and Etter, 2012 had substantial loss to follow up, which 
according to its author is common for internet studies. 
Lastly, the meta-analysis could not address “offset effects” because that distinction was 
not discussed in the included studies. 
Conclusion 
The meta-analysis shows that impulsivity increases post smoking cessation.  These 
findings imply that smoking cessation may have an effect on decision making.  
Additionally higher rates of impulsivity have been associated with smoking relapse.  
(Doran, Spring, McChargue, Peradia, & Richmond, 2004).  In order to assist better in the 
development of individual treatments, a better understanding is needed of how increased 
impulsivity influences cognitive behavior and relapse rates.  These findings support the 
inclusion of impulsivity as a criterion for nicotine withdrawal. 
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APPENDIX 
Meta-Analysis of Studies Investigation of the Effect of Smoking Cessation 
Impatience Performed Using Excel 2010 
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